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1. Introduction 
It is well established that different substrates affect 
the light absorption of microsomal cytochrome P-450 
differently. The substrates have been classified into 
two types [ 1 ] : type I substrates which cause a shift 
of the Soret band absorption to shorter wavelength, 
indicating an increase in high spin character, and type 
II substrates which cause a shift of the Soret band to 
longer wavelength, indicating an increase in low spin 
character. The different spectral changes resulting 
from the interaction of various substrates with micro- 
somal cytochrome P-450 poses the question whether 
the substrates interact with different cytochrome 
P-450 species or with different sites on a single species 
of cytochrome P-450. Many studies concerned with 
purification of liver microsomal cytochrome P-450 
show evidence for different forms of the hemoprotein 
[2-71. 
We will report here observations by light absorp- 
tion and EPR suggesting that SKF 525-A (diethyl- 
aminoethyl-2,2-diphenylvalerate) and metyrapone 
(MP), inhibitors of cytochrome P-450~linked reactions 
[8], react selectively with different fractions of micro- 
somal cytochrome P-450. The reactions are indepen- 
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dent of each other, strongly indicating the presence of 
at least two forms of the hemoprotein. The ratio 
between the two fractions of cytochrome P-450 is 
different in microsomes from normal rats and from 
rats pretreated with phenobarbital (PB); essentially 
only the form reacting with MP is induced by PB 
treatment. 
In addition the interaction of other inhibitors and 
substrates with cytochrome P-450 are being investi- 
gated using the same technique. These seem to bind 
with less selectivity and show different degrees of 
competition. 
In general binding to cytochrome P-450 occurs in 
two phases: a strong binding phase and a gradual 
binding of low affinity. 
2. Materials and methods 
The animals used were male Sprague-Dawley rats 
weighing 150-250 g. Liver microsomes were isolated 
[9] and washed in 0.15 M KCl. Phenobarbital, sodium 
salt, (80 mg/kg body weight) was injected intraperi- 
toneally once daily for three consecutive days. Cyto- 
chrome P-450 and protein were determined using the 
methods of Omura and Sato [lo] and Lowry et al. 
[ 111 , respectively. 
Metyrapone was obtained from Ciba-Geigy and 
camphor from the British Drug Houses Ltd. SKF 
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525-A (Smith, Klein & French laboratories) and 
lidocaine (Astra Pharmaceutical Co.) were used as the 
hydrochlorides. 
The spectral changes produced by addition of 
various reactants to suspensions of microsomes at a 
temperature of about 25°C were recorded with an 
Aminco DW 2 UV-VIS spectrophotometer. The 
microsomal suspension, containing 50 mM Tris-Cl, 
pH 7.5, 15 mM KC1 and 3-6 mg protein/ml in a 
total vol of 6 ml, was equally distributed between 
reference and sample cuvettes having a 1 cm light 
path. The substrates were dissolved in water and 
added successively to the sample cuvette or to both 
cuvettes, and in some cases finally to the reference 
cuvette in the order specified in the figure legends. 
An equivalent volume of water was added to the 
other cuvette. Care was taken to measure the initial 
part of the titration curve whenever a new substrate 
was used. 
The EPR spectra were recorded and g-values were 
measured as described elsewhere [12] Samples were 
measured at 77 K using a conventional liquid N2 cold 
finger and at 3.6 K using a He-flow system (Oxford 
Instruments, SCL 5002 ESR 9). The concentrations 
of high and low spin components were determined 
according to Aasa and VInng%d [ 131 using 1 mM 
Cu*’ in 10 mM EDTA solution as reference. For the 
high spin signals a correction was applied assuming a 
zero field splitting of 8.63 cm-’ between the lowest 
and middle Kramers doublets [ 141 and Boltzmann 
distribution between the levels. 
3. Results and discussion 
As can be seen from fig.1, the presence of MP was 
practically without effect on the light absorption 
change resulting from titration of oxidized microsomal 
cytochrome P-450 with SKF 525-A. This behaviour 
is further indicated by the data shown in fig.2, where 
addition of equal amounts of MP to the sample and 
reference cuvettes had no or only a very minor effect 
on the SKF 525-A titration curves. Both the spectral 
amplitude and the shift in the wavelength of maximum 
absorbance induced by SKF 525-A were unaffected 
by MP. Similar results were obtained in analogous 
experiments where titration with MP was carried out 
in the absence or presence of SKF 525-A. The general 
10 20 
[SKF 529A]/[P-4501 
Fig.1, Titration with SKI: 525-A of oxidized cytochrome 
P-450 in microsomes from untreated (control) rats in absence 
(o-o) and in presence (0-o) of 37 PM metyrapone (MT’) 
in both cuvettes. The absorbance difference between 390 nm 
and 420 nm was measured after consecutive additions of SKI: 
525-A to the sample cuvette. The concentration of cytochrome 
P-450 was 3.2 PM. The inset shows the low concentration 
region on an expanded scale. 
nature of the titration curves was the same, irrespective 
of whether microsomes from control or from PB 
treated rats were used. The spectral changes obtained 
by adding both MP and SKF 525-A were always the 
algebraic sum of the type I (SKF 525-A) and type II 
(MP) difference spectra. This finding demonstrates 
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Fig.2. Optical difference titrations of microsomes from 
phenobarbital treated rats with SKF 525-A (o-o) and 
lidocame (o---o) added to the sample cuvette. Intermediately 
metyrapone (A, A) was added to the sample as well as to the 
reference cuvettc. The concentration of cytochrome P-450 
was 10 PM. 
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that there is essentially no interaction between the 
binding of MP and SKF 525-A and suggests that these 
two reactants bind independently of each other to 
different fractions of microsomal cytochrome P-450. 
As shown in fig.2, a quite different pattern is 
observed for the interaction between lidocaine, which 
like SKF 525-A gives a type I difference spectrum, and 
MP. It can be seen that the spectral change induced by 
lidocaine is completely abolished by addition of MP. 
The subsequent addition of lidocaine gives only a 
very minor spectral change. This strong interaction is 
only possible if the two reactants compete for the 
same binding site or at least bind to the same 
molecule. 
An outstanding feature of the curves shown in 
figs.1 and 2 are the relatively large spectral changes 
that occur with reactant/P-450 molar ratios <<l. The 
initial parts of the curves clearly demonstrate the 
presence of a strong substrate-binding portion of 
cytochrome P-450 responsible for about one half of 
the maximal spectral change. At higher reactant 
concentrations, binding to sites of lower affinity 
causes a considerable further increase in the spectral 
change. However, even at very high substrate/P-450 
molar ratios, no single substrate studied (SKF 525-A, 
lidocaine and several other type I substrates) was able 
to convert the total amount of cytochrome P-450 to 
a high spin state. 
If we apply to our system the difference extinction 
coefficient (Ae390_420 nm rr, 130 mM_’ cm-‘) 
reported for the conversion of purified Pseudomonas 
putida cytochrome P-4.50 from a low spin to a high 
spin state [ 151, we find that in control microsomes 
20-35s of the total cytochrome P-450 may be con- 
verted to a high spin state by reaction with SKF 525-A; 
the corresponding figure for microsomes from PB 
treated rats in which the level of cytochrome P-450 
was 2 to 3 times higher than in control microsomes 
was only S- 15%. These values are in reasonable agree- 
ment with our preliminary analysis of optical absolute 
spectra of microsomal cytochrome P-450 and indicate 
that about the same absolute amount of cytochrome 
P-450 reacted with SKF 525-A in the two types of 
microsomes. This is particularly well demonstrated in 
fig.3, where the initial titrations with SKF 525-A show 
that, on the basis of total protein, very nearly the 
same optical change is obtained with microsomes from 
control and from PB treated rats. Treatment of rats 
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Fig.3. Optical titrations with three type I substrates of cyto- 
chrome P-450 in microsomes from control rats (o-o) and 
from phenobarbital treated rats (o--o). In the first part 
the substrates were added to the sample cuvette in the order: 
(a) SKI; 525-A, (b) lidocaine and (c) camphor. In the second 
part, in the case of microsomes from control rats, they were 
added in the reverse order to the reference cuvctte. The con- 
centrations of cytochrome P-450 were: 3.4 and 9.2 PM and 
of protein 4.1 and 4.6 mg/ml in microsomal suspensions from 
control and phenobarbital treated rats, respectively. 
with PB is known to induce more cytochrome P-450 
with only relatively small change of the total protein 
content of the microsomes (approx. 30% after 72 h 
PB treatment) [16]. On the other hand, the spectral 
changes induced by MP in microsomes from control 
rats and in microsomes from PB treated rats are closely 
proportional to the concentrations of cytochrome 
P-450. These findings demonstrate that the cytochrome 
P-450 induced by PB treatment is almost entirely in a 
form which binds MP and not SKF 525-A. 
Fig.3 also provides evidence that liver microsomal 
cytochrome P-450 can be further divided into sub- 
fractions which differ in their binding specificity for 
type I substrates such as SKF 525-A, lidocaine, and 
camphor. The relative amounts of these subfractions 
are altered by pretreatment of animals with PB. The 
remarkably abrupt increase in the spectral change 
associated with the initial addition of each new sub- 
strate clearly demonstrates the presence of different 
binding sites or fractions. Furthermore, the limited 
spectral change obtained for each substrate presum- 
ably reflects the amount of free cytochrome P-450 
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possessing a high affinity binding site for the substrate 
in question. Apart from this heterogeneity of liver 
microsomal cytochrome P-450, the curves in fig.3 also 
reveal that there is partial competition between the 
substrates, an overlap in the specificities of different 
subfractions. For example, when SKF 525-A is added 
alone to control microsomes, it gives a spectral change 
that is about three times as large as when it is added 
in the presence of an excess of camphor and lidocaine. 
Conversely, if camphor is added alone to the same 
microsomes, it causes a spectral change that is 6 to 7 
times larger than that obtained in the presence of an 
excess of SKF 525-A and lidocaine. 
Some EPR results that complement the optical 
observations are summarized in table 1. The low field 
absorption-like wings of the low spin EPR spectra of 
cytochrome P-450 measured at 77 K are shown in 
fig.4. Microsomes from control rats without added 
reactant show one low spin component (g = 2.42, 
2.24, 1.92) which accounts for 64% of the total cyto- 
chrome P-450. Upon addition of MP two low spin 
components are found, the earlier component now 
accounting for 41% and one or possibly two other 
components with shifted g-values (g = 2.47,2.26, 
1.90) accounting for 49%. Microsomes from PB treated 
rats without any addition give two closely situated 
Sample 
source 
(nmoles 
P-450/mg 
protein) 
Added 
reactant 
Control 
rats 
(0.50) 
none 
MP 
SKF 525-A 
PB treated none 
rats MP 
(1.70) SKI: 525-A 
(0.50) MP 
(1.20) MP 
(0.50) SKI: 525-A 
(1.20) SKF 525-A 
Table 1 
Fractions of cytochrome P-450 appearing in the EPR signals observed 
Amount of 
P-450 on 
which 
fractional 
figures 
are based 
total 
total 
total 
Original low spin 
component(s) 
centered at g = 
2.42, 2.24, 1.92 
measured 
(calculated) 
0.64 
0.41 
0.69 
Low spin 
component(s) 
of MP complex 
centered at g = 
2.47, 2.26, 1.90 
measured 
(calculated) 
0 
0.49 
0 
High spin 
component 
centered at .t~ = 
8.1, 3.6, 1.7 
measured 
(calculated) 
0.11 
0.06 
0.30 
- 
total 
total 
total 
control 
fraction 
PB induced 
fraction 
0.86 0 0.07 
0.20 0.69 0.01 
0.80 0 0.20 
(0.41) (0.49) 
(0.11) (0.77) 
control 
fraction 
(0.19) 
PB induced 
fraction 
(0.10) 
The abbreviations used are: MP, metyrapone; SKF 525-A, diethylaminoethyl-2,2diphenylvalerate; PB, phenobarbital. 
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Fig.4. EPR spectra of low spin microsomal cytochrome P-450 
without and with added metyrapone (MP). The low field 
absorption-like wings were recorded at 77 K. Microsome 
suspensions from control rats at bottom (C) and from pheno- 
barbital treated rats at top (1’13). The column at the right 
indicates the concentration of MP added. The concentration 
of cytochrome p-4-450 was in microsomes from control rats, 
42 MM and from PB treated rats, 105 pM. The EPR conditions 
were: microwave power, 30 mW; microwave frequency, 9.12 
GHz; modulation amplitude, 1.2 mT; scanning rate, 20 
mT/min. The receiver gain was increased by a factor of 2 for 
the control samples. 
components centered at the same g-values as for 
microsomes from control rats. The total signal inten- 
sity corresponds to 86% of all cytochrome P-450. 
Addition of MP gives in this case a major fraction of 
69’i: at the shifted g-values and a minor fraction of 
20% at the original g-values. The spectral components 
(g = 2.47, 2.26, 1.90) appearing after addition of MP 
is believed to represent the complex of cytochrome 
P-450 with MP. In agreement with the optical data 
much more of this complex is formed in microsornes 
from PB treated rats than from control rats, i.e. 69 
and 49%, respectively, of total cytochrome P-450. 
The microsomes from PB treated rats contained 1.70 
nmol cytochromc P-450 per mg of protein, whereas 
those from control rats contained 0.50 nmol cyto- 
chrome P-450 per mg of protein. If we assume that 
in the microsomes from PB treated rats a ‘control’ 
fraction of 0.50 nmol cytochrome P-450 per mg of 
protein behaves identically to the cytochrome P-450 
in control microsomes, we find that for the PB 
inducecl fraction (1.20 nmol per nig of protein) upon 
addition of MP 77% is found in the signal of the MP 
complex and 11X in the original signal. These figures 
should be compared with 49 and 41%, respectively, 
for the control fraction. 
We also measured at 3.6 K the high spin signals at 
g = 8.1 (not shown) assuming the complete set of 
g-values to be g = 8.1, 3.6, 1 .7. In microsomes from 
control rats addition of MP decreased this component 
from 11 to 6%, whereas addition of SKF 525-A 
increased it to 30%. In microsomes from PB treated 
rats addition of MP decreased the high spin component 
from 7 to 1T, and addition of SKF 525-A increased it 
to 20%. Again, we may calculate that addition of 
SKF 525-A to the PB induced fraction increases the 
high spin component with 10% as compared with 19% 
in the control fraction. 
While these results obtained by low temperature 
EPR are not completely consistent with the light 
absorption titrations at room temperature, they 
nevertheless how that the PB induced fraction of 
cytochrome P-450 has less ability to react with SKF 
525-A than the control fraction. The difference 
between the two sets of experiments might be due to 
differences in temperature dependent spin equilibria 
of cytochrome P-450 in the different microsomes. 
Other series of EPR experiments have been evalu- 
ated in the same way and gave similar results. It is 
worth noting that the sum of the low spin component 
measured at 77 K and the high spin component meas- 
ured at 3.6 K usually was close to 100% of the total 
cytochrome P-450. 
It was observed that addition of SKF 525-A slightly 
changed the shape of the low spin EPR signal without 
noticeable changing the corresponding concentration. 
It was also observed that addition of both MP and 
SKF 525-A resulted in low spin and high spin contri- 
butions intermediate to those obtained with either 
reactant alone. These results suggest a competition 
between the two reactants, in contrast to the optical 
results. However, we hesitate to draw any extensive 
conclusions from these EPR observations without 
making more detailed studies of factors such as con- 
centration and temperature dependencies. In general 
it is dangerous to generalize from low temperature 
EPR results to conditions in an aqueous solution at 
room temperature, especially if corroborating light 
absorption data are not available. 
298 
Volume 60, number 2 FEBS LETTERS December 1975 
The main conclusions remain as follows: There are 
at least two species or modifications of cytochrome 
P-450 in liver microsomes. PB treatment of rats 
induces the formation of a form of cytochrome P-450 
which binds MP tightly and only to a very much lesser 
extent combines with SKF 525-A. The optical experi- 
ments at room temperature suggest complete indepen- 
dence of the two binding processes, whereas the low 
temperature EPR results indicate some competition 
and interaction between them. 
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